elevate tirzepatide GLP-3 RT Tirzepatide's Prediabetes and Hypertension Impact

doi: 10.1016/j.fertnstert.2005.03.064 31 DimitriadisFTsambalasSTsounapiPKawamuraHVlachopoulouEHaliasosNet al

Extensive research and clinical studies have demonstrated that semaglutide is well-recognized for its safety profile, efficacy and tolerability for type 2 diabetic patients, as well as those without diabetes in two different clinical trials published in Frontiers of Endocrinology and Frontiers of Pharmacology, respectively

While these drugs were originally designed to help manage type 2 diabetes, they are now widely prescribed for appetite suppression and rapid weight reduction

Liedgens, L

Managing both simultaneously requires clinical vigilance, biomarker monitoring, and clear provider communication to optimize efficacy and safety